Magnus Isaksson
Director/Board Member chez PULSION MEDICAL SYSTEMS SE
Profil
Magnus Isaksson founded Halo Genomics AB in 2008.
Mr. Isaksson also currently works at PULSION Medical Systems SE, as Director from 2022.
Postes actifs de Magnus Isaksson
| Sociétés | Poste | Début |
|---|---|---|
| PULSION MEDICAL SYSTEMS SE | Director/Board Member | 30/06/2022 |
Anciens postes connus de Magnus Isaksson
| Sociétés | Poste | Fin |
|---|---|---|
Halo Genomics AB
 Halo Genomics AB Medical/Nursing ServicesHealth Services Halo Genomics AB operates as a genomics company. It offers sample preparation solutions to provide scientists with enabling tools to analyze the genetic foundation of disease. The firm provides reagent kits and a service for the multiplex amplification of exons for targeted re-sequencing that includes selector probe library design and synthesis, target regions amplification, and quality control of the enrichment. The company was founded by Olle Ericsson in 2008 and is headquartered in Uppsala, Sweden. | Founder | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PULSION MEDICAL SYSTEMS SE | Distribution Services |
| Entreprise privées | 1 |
|---|---|
Halo Genomics AB
Halo Genomics AB Medical/Nursing ServicesHealth Services Halo Genomics AB operates as a genomics company. It offers sample preparation solutions to provide scientists with enabling tools to analyze the genetic foundation of disease. The firm provides reagent kits and a service for the multiplex amplification of exons for targeted re-sequencing that includes selector probe library design and synthesis, target regions amplification, and quality control of the enrichment. The company was founded by Olle Ericsson in 2008 and is headquartered in Uppsala, Sweden. | Health Services |
